Through bioinformatics analysis, several molecules, including dihydropyrimidinase-related protein 2 (DPYSL2), were identified that are expressed differentially in glioblastoma as compared to normal tissues, providing promising reference biomarkers for follow-up research and treatment (40). The gene discussed is DPYSL2; the disease is glioblastoma.